## Published 13 November 2020

The National Diabetes Inpatient Audit - Harms (NaDIA-Harms) is a continuous collection of serious inpatient harms that affect people with diabetes. Data collection began on 1 May 2018. The 2019 report covers NaDIA-Harms data collected between May 2018 and October 2019. All acute hospitals in England should take part in the audit to help reduce the rates of serious inpatient harms by informing their quality improvement work.

## Serious Inpatient Harms Affecting People With Diabetes Trust Participation

NaDIA-Harms monitors four uncommon complications which might happen to people with diabetes during an inpatient stay:
Since collection started on 1 May 2018:
Hypoglycaemic rescue - low blood glucose levels causing harm and requiring injectable rescue treatment.

Hyperglycaemic emergencies –
dangerously high blood glucose levels:
•
Diabetic Ketoacidosis (DKA) –
Mainly type 1 diabetes.
•
Hyperosmolar hyperglycaemic state (HHS) - Mainly type 2 diabetes.

## Hospital Acquired Inpatient Diabetic Foot Ulcer (Dfu)

Notes: 1. Eligibility inferred from NaDIA snapshot participation (2015-19). 2. One or more inpatient harm submission or any verified monthly nil submission. 3. As for note 2, in each quarterly period. 

## Type Of Inpatient Harm

- **Acute hospitals** should all participate in NaDIA-Harms,.
The audit 

- **Healthcare professionals** should be aware of the increased risk of harm in 
recommends...

hospital inpatients with higher risk characteristics.

ascertainment in NaDIA-Harms 
ranges from 6 (diabetic foot ulcer) to 20 per cent (DKA).

## High Risk Characteristics

Higher risk characteristics found for all three inpatient harms1 tested were:
Note: 1. HHS was excluded due to the small number of episodes reported (80).